查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球急性肺損傷治療市場（療法：機械通氣、藥物療法、液體管理等；最終用戶：醫院、專科中心等）-行業分析、規模、份額、增長、趨勢、預測，2022 -2031 年
市場調查報告書
商品編碼
1229632

全球急性肺損傷治療市場（療法：機械通氣、藥物療法、液體管理等；最終用戶：醫院、專科中心等）-行業分析、規模、份額、增長、趨勢、預測，2022 -2031 年

Acute Lung Injury Treatment Market (Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, & Others; & End-user: Hospitals, Specialty Centers, & Others) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 158 Pages | 商品交期: 2-10個工作天內

價格

本報告介紹了 2017 年至 2031 年全球急性肺損傷治療市場的收入，基準年為 2022 年，預測年為 2031 年。 它還介紹了 2022 年至 2031 年全球急性肺損傷治療市場的複合年增長率 (CAGR %)。

這份報告是廣泛研究的結果。 在初步研究中，分析師對主要思想領袖、行業領袖和輿論製造者進行訪談，他們提供了大量的研究工作。 二次研究查閱了主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解急性肺損傷治療市場。

該報告深入探討了全球急性肺損傷治療市場的競爭格局。 已經確定了在全球急性肺損傷治療市場上運營的主要參與者，並根據各種屬性對每家公司進行了介紹。 公司概況、財務狀況、近期市場發展和 SWOT 是本報告中描述的全球急性肺損傷治療市場參與者的屬性。

內容

第一章前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目標
  • 調查要點

第 2 章假設和研究方法

第 3 章執行摘要：全球急性肺損傷治療市場

第 4 章市場概述

  • 介紹
    • 段定義
  • 概覽
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • 2017-2031 年急性肺損傷藥物全球市場分析和預測
    • 市場收入預測

第 5 章關鍵見解

  • 區域/全球監管情景
  • 重大行業事件（合併、收購、合作、批准等）
  • COVID-19 大流行對行業的影響（價值鏈以及短期、中期和長期影響）

第 6 章急性肺損傷藥物的全球市場分析和預測：按治療分類

  • 介紹和定義
  • 重大發現/發展
  • 2017-2031 年各療法的市場價值預測
    • 機械通氣
    • 藥物治療
    • 液體管理
    • 其他
  • 市場吸引力：按處理方法

第 7 章急性肺損傷藥物的全球市場分析和預測：最終用戶

  • 介紹和定義
  • 重大發現/發展
  • 市場價值預測：按最終用戶分類，2017-2031 年
    • 醫院
    • 專業中心
    • 其他
  • 市場吸引力：按最終用戶

第 8 章急性肺損傷藥物的全球市場分析和預測：按地區

  • 主要發現
  • 市場價值預測：按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按國家/地區

第9章北美急性肺損傷治療市場分析及預測

  • 介紹
    • 主要發現
  • 2017-2031 年各療法的市場價值預測
    • 機械通氣
    • 藥物治療
    • 液體管理
    • 其他
  • 市場價值預測：按最終用戶分類，2017-2031 年
    • 醫院
    • 專業中心
    • 其他
  • 2017-2031 年各個國家/地區的市場價值預測
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 通過治療
    • 最終用戶
    • 按國家

第 10 章歐洲急性肺損傷治療市場分析和預測

  • 介紹
    • 主要發現
  • 2017-2031 年各療法的市場價值預測
    • 機械通氣
    • 藥物治療
    • 液體管理
    • 其他
  • 市場價值預測：按最終用戶分類，2017-2031 年
    • 醫院
    • 專業中心
    • 其他
  • 2017-2031 年按國家/次區域劃分的市場價值預測
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 市場吸引力分析
    • 通過治療
    • 最終用戶
    • 按國家/地區

第 11 章亞太地區急性肺損傷治療市場分析與預測

  • 介紹
    • 主要發現
  • 2017-2031 年各療法的市場價值預測
    • 機械通氣
    • 藥物治療
    • 液體管理
    • 其他
  • 市場價值預測：按最終用戶分類，2017-2031 年
    • 醫院
    • 專業中心
    • 其他
  • 2017-2031 年按國家/次區域劃分的市場價值預測
    • 中國
    • 日本
    • 印度
    • 澳大利亞和新西蘭
    • 其他亞太地區
  • 市場吸引力分析
    • 通過治療
    • 最終用戶
    • 按國家/次區域

第 12 章拉丁美洲急性肺損傷治療市場分析和預測

  • 介紹
    • 主要發現
  • 2017-2031 年各療法的市場價值預測
    • 機械通氣
    • 藥物治療
    • 液體管理
    • 其他
  • 市場價值預測：按最終用戶分類，2017-2031 年
    • 醫院
    • 專業中心
    • 其他
  • 2017-2031 年按國家/次區域劃分的市場價值預測
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 市場吸引力分析
    • 通過治療
    • 最終用戶
    • 按國家/地區

第13章中東和非洲急性肺損傷藥物市場分析及預測

  • 介紹
    • 主要發現
  • 2017-2031 年各療法的市場價值預測
    • 機械通氣
    • 藥物治療
    • 液體管理
    • 其他
  • 市場價值預測：按最終用戶分類，2017-2031 年
    • 醫院
    • 專業中心
    • 其他
  • 2017-2031 年按國家/次區域劃分的市場價值預測
    • 海灣合作委員會國家
    • 南非
    • 其他中東和非洲地區
  • 市場吸引力分析
    • 通過治療
    • 最終用戶
    • 按國家/地區

第14章競爭格局

  • 市場競爭對手 - 競爭矩陣（按層次結構和公司規模）
  • 各公司的市場份額分析（2021 年）
  • 公司簡介
    • Mayo Clinic
    • Johns Hopkins Hospital
    • Cleveland Clinic
    • Great Ormond Street Hospital
    • Apollo Hospitals
    • Tokyo Medical University Hospital
    • The Prince Charles Hospital
    • Helios Hospital
    • Aster Hospitals
Product Code: TMRGL85373

The report provides revenue of the global acute lung injury treatment market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute lung injury treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the acute lung injury treatment market.

The report delves into the competitive landscape of the global acute lung injury treatment market. Key players operating in the global acute lung injury treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global acute lung injury treatment market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Acute Lung Injury Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Acute Lung Injury Treatment Market Analysis and Forecast, 2017 - 2031
    • 4.4.1. Market Revenue Projection (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Scenario by Region/Globally
  • 5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)
  • 5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

6. Global Acute Lung Injury Treatment Market Analysis and Forecast, by Therapy

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Therapy, 2017 - 2031
    • 6.3.1. Mechanical Ventilation
    • 6.3.2. Pharmacotherapy
    • 6.3.3. Fluid Management
    • 6.3.4. Others
  • 6.4. Market Attractiveness, by Therapy

7. Global Acute Lung Injury Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2017 - 2031
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Centers
    • 7.3.3. Others
  • 7.4. Market Attractiveness, by End-user

8. Global Acute Lung Injury Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness, by Country/Region

9. North America Acute Lung Injury Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Therapy, 2017 - 2031
    • 9.2.1. Mechanical Ventilation
    • 9.2.2. Pharmacotherapy
    • 9.2.3. Fluid Management
    • 9.2.4. Others
  • 9.3. Market Value Forecast, by End-user, 2017 - 2031
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Centers
    • 9.3.3. Others
  • 9.4. Market Value Forecast, by Country, 2017 - 2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Therapy
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Acute Lung Injury Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Therapy, 2017 - 2031
    • 10.2.1. Mechanical Ventilation
    • 10.2.2. Pharmacotherapy
    • 10.2.3. Fluid Management
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by End-user, 2017 - 2031
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Centers
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Therapy
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Acute Lung Injury Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Therapy, 2017 - 2031
    • 11.2.1. Mechanical Ventilation
    • 11.2.2. Pharmacotherapy
    • 11.2.3. Fluid Management
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by End-user, 2017 - 2031
    • 11.3.1. Hospitals
    • 11.3.2. Specialty Centers
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Therapy
    • 11.5.2. By End-user
    • 11.5.3. By Country/sub-region

12. Latin America Acute Lung Injury Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Therapy, 2017 - 2031
    • 12.2.1. Mechanical Ventilation
    • 12.2.2. Pharmacotherapy
    • 12.2.3. Fluid Management
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by End-user, 2017 - 2031
    • 12.3.1. Hospitals
    • 12.3.2. Specialty Centers
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Therapy
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Acute Lung Injury Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Therapy, 2017 - 2031
    • 13.2.1. Mechanical Ventilation
    • 13.2.2. Pharmacotherapy
    • 13.2.3. Fluid Management
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by End-user, 2017 - 2031
    • 13.3.1. Hospitals
    • 13.3.2. Specialty Centers
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017 - 2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Therapy
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 14.2. Market Share Analysis By Company (2021)
  • 14.3. Company Profiles
    • 14.3.1. Mayo Clinic
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Business Strategies
      • 14.3.1.5. Recent Developments
    • 14.3.2. Johns Hopkins Hospital
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Business Strategies
      • 14.3.2.5. Recent Developments
    • 14.3.3. Cleveland Clinic
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Business Strategies
      • 14.3.3.5. Recent Developments
    • 14.3.4. Great Ormond Street Hospital
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Business Strategies
      • 14.3.4.5. Recent Developments
    • 14.3.5. Apollo Hospitals
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Business Strategies
      • 14.3.5.5. Recent Developments
    • 14.3.6. Tokyo Medical University Hospital
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Business Strategies
      • 14.3.6.5. Recent Developments
    • 14.3.7. The Prince Charles Hospital
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Business Strategies
      • 14.3.7.5. Recent Developments
    • 14.3.8. Helios Hospital
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Business Strategies
      • 14.3.8.5. Recent Developments
    • 14.3.9. Aster Hospitals
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Business Strategies
      • 14.3.9.5. Recent Developments

List of Tables

  • Table 01: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 02: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 05: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 06: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 08: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 09: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 12: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 15: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 18: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Acute Lung Injury Treatment Market Value Share, by Therapy, 2021
  • Figure 04: Acute Lung Injury Treatment Market Value Share, by End-user, 2021
  • Figure 05: Acute Lung Injury Treatment Market Value Share, by Region, 2021
  • Figure 06: Global Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 07: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 08: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Mechanical Ventilation, 2017-2031
  • Figure 09: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Pharmacotherapy, 2017-2031
  • Figure 10: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Fluid Management, 2017-2031
  • Figure 12: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Others, 2017-2031
  • Figure 13: Global Acute Lung Injury Treatment Market Value Share Analysis, by End-user 2021 and 2031
  • Figure 14: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user 2022-2031
  • Figure 15: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Hospitals, 2017-2031
  • Figure 16: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Specialty Centers, 2017-2031
  • Figure 17: Global Acute Lung Injury Treatment Market Value (US$ Mn), by Others, 2017-2031
  • Figure 18: Global Acute Lung Injury Treatment Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 19: Global Acute Lung Injury Treatment Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 20: North America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 21: North America Acute Lung Injury Treatment Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 22: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 23: North America Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 24: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy 2022-2031
  • Figure 25: North America Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 26: North America Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 27: Europe Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 28: Europe Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 29: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 30: Europe Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 31: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 32: Europe Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 33: Europe Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 34: Asia Pacific Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 35: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 36: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 37: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 38: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 39: Asia Pacific Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 40: Asia Pacific Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 41: Latin America Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 43: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 44: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 45: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 46: Latin America Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 47: Latin America Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 48: Middle East & Africa Acute Lung Injury Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 50: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 51: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 52: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 53: Middle East & Africa Acute Lung Injury Treatment Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 54: Middle East & Africa Acute Lung Injury Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 55: Company Share Analysis